Nasal Dilator Strip is an Effective Placebo Intervention for Severe Obstructive Sleep Apnea.

STUDY OBJECTIVES The aim of this study was to evaluate the effects of nasal dilator strip (NDS) as a placebo intervention compared with continuous positive airway pressure (CPAP) treatment in patients with severe obstructive sleep apnea (OSA). METHODS Patients were treated with both NDS and nasal CPAP. The sequence was randomized and interposed by 15 days of washout. Polysomnography was performed at baseline and on the first night of intervention with NDS and CPAP (titration). The Epworth Sleepiness Scale (ESS), Functional Outcomes of Sleep Questionnaire (FOSQ), and Beck Depression Inventory (BDI) were completed at baseline and at the end of both interventions. A questionnaire on the comfort and satisfaction (0 = no to 10 = total) was completed at the end of each intervention. RESULTS Twenty-six patients with OSA were evaluated (19 male; age 46.3 ± 9.3 y; body mass index 33.2 ± 5.1 kg/m2; ESS 15.8 ± 4.1; apnea-hypopnea index 60.7 ± 25.2). Adherence was high in both NDS (98%) and CPAP interventions (94%; 5.8 ± 1.7 h/night). In contrast to the baseline values, NDS intervention had no significant effect on all polysomnographic parameters, but NDS improved somnolence (ESS 13.0 ± 5.4, p = 0.001) and depressive symptoms (BDI 7.7 ± 6.9, p = 0.005). Reported satisfaction was significantly higher for CPAP than for NDS (sleep quality 9.2 ± 0.8 vs. 6.1 ± 2.1; wake up at morning: 8.6 ± 1.2 vs. 6.0 ± 2.2; daily activities: 8.9 ± 1.4 vs. 5.8 ± 1.5; quality of life: 8.3 ± 2.1 vs. 3.8 ± 3.5, p < 0.001), but similar low levels of difficulty for both interventions were observed (1.3 ± 2.2 vs. 0.3 ± 1.3, p = 0.098). CONCLUSIONS Our data indicate that NDS is an attractive placebo intervention for randomized controlled trials evaluating the effects of CPAP in sleepy patients with OSA.

[1]  Panagiotis Matsangas,et al.  The Epworth Sleepiness Scale in Service Members with Sleep Disorders. , 2019, Military medicine.

[2]  M. Fortin,et al.  Interventions for improving outcomes in patients with multimorbidity in primary care and community settings. , 2016, The Cochrane database of systematic reviews.

[3]  M. Preisig,et al.  Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. , 2015, The Lancet. Respiratory medicine.

[4]  F. Benedetti,et al.  Placebo‐induced decrease in fatigue: evidence for a central action on the preparatory phase of movement , 2015, The European journal of neuroscience.

[5]  N. Marshall,et al.  Ethics, consent and blinding: lessons from a placebo/sham controlled CPAP crossover trial , 2015, Thorax.

[6]  Tetyana Kendzerska,et al.  Obstructive sleep apnea and incident diabetes. A historical cohort study. , 2014, American journal of respiratory and critical care medicine.

[7]  D. Newby,et al.  The effect of continuous positive airway pressure therapy on arterial stiffness and endothelial function in obstructive sleep apnea: a randomized controlled trial in patients without cardiovascular disease. , 2013, Sleep medicine.

[8]  P. Strollo,et al.  Success in Blinding to Group Assignment With Sham-CPAP , 2013, Biological research for nursing.

[9]  Fabrizio Benedetti,et al.  Placebo and the new physiology of the doctor-patient relationship. , 2013, Physiological reviews.

[10]  T. Young,et al.  Increased prevalence of sleep-disordered breathing in adults. , 2013, American journal of epidemiology.

[11]  Gail M. Sullivan,et al.  Using Effect Size-or Why the P Value Is Not Enough. , 2012, Journal of graduate medical education.

[12]  S. Redline,et al.  The use of nasal dilator strips as a placebo for trials evaluating continuous positive airway pressure , 2012, Clinics.

[13]  N. Marshall,et al.  Continuous positive airway pressure reduces postprandial lipidemia in obstructive sleep apnea: a randomized, placebo-controlled crossover trial. , 2011, American journal of respiratory and critical care medicine.

[14]  L. Colloca,et al.  Role of expectations in health , 2011, Current opinion in psychiatry.

[15]  A. Newman,et al.  Prospective Study of Obstructive Sleep Apnea and Incident Coronary Heart Disease and Heart Failure: The Sleep Heart Health Study , 2010, Circulation.

[16]  Marie Diener-West,et al.  Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. , 2010, American journal of respiratory and critical care medicine.

[17]  David A. Schulman,et al.  Evaluation of sham-CPAP as a placebo in CPAP intervention studies. , 2010, Sleep.

[18]  S. Tufik,et al.  Obstructive sleep apnea syndrome in the Sao Paulo Epidemiologic Sleep Study. , 2009, Sleep medicine.

[19]  A. Malhotra,et al.  Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. , 2009, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[20]  B. Oken.  THE PLACEBO TREATMENTS IN NEUROSCIENCES: NEW INSIGHTS FROM CLINICAL AND NEUROIMAGING STUDIES , 2009, Neurology.

[21]  P. Calverley,et al.  Cardiovascular and metabolic effects of CPAP in obese males with OSA , 2007, European Respiratory Journal.

[22]  Terry Young,et al.  Longitudinal association of sleep-related breathing disorder and depression. , 2006, Archives of internal medicine.

[23]  Deborah A. Nichols,et al.  The Apnea Positive Pressure Long-term Efficacy Study (APPLES): rationale, design, methods, and procedures. , 2006, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[24]  D. M. Smith,et al.  Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients , 2006, European Respiratory Journal.

[25]  Max Hirshkowitz,et al.  Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. , 2006, Sleep.

[26]  Conrad Iber,et al.  Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. , 2006, Sleep.

[27]  W. De Backer,et al.  First night effect for polysomnographic data in children and adolescents with suspected sleep disordered breathing , 2005, Archives of Disease in Childhood.

[28]  A. Campbell,et al.  Randomised controlled crossover trial of humidified continuous positive airway pressure in mild obstructive sleep apnoea , 2005, Thorax.

[29]  P. Petrovic,et al.  Placebo and Opioid Analgesia-- Imaging a Shared Neuronal Network , 2002, Science.

[30]  D. Navajas,et al.  Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with an optimized placebo. , 2001, American journal of respiratory and critical care medicine.

[31]  H. Brünig,et al.  Effect of nasal-valve dilation on obstructive sleep apnea. , 2000, Chest.

[32]  D. Navajas,et al.  Sham continuous positive airway pressure for placebo-controlled studies in sleep apnoea , 1999, The Lancet.

[33]  W. Dimpfel,et al.  Effect of the external nasal dilator Breathe Right on snoring. , 1998, European journal of medical research.

[34]  P. Rombaux,et al.  Effects of Breathe Right on snoring: a polysomnographic study. , 1998, Respiratory medicine.

[35]  A I Pack,et al.  An instrument to measure functional status outcomes for disorders of excessive sleepiness. , 1997, Sleep.

[36]  J. Ulfberg,et al.  Effect of Breathe Right nasal strip on snoring. , 1997, Rhinology.

[37]  J. Hedner,et al.  The effects of nasal dilation on snoring and obstructive sleep apnea. , 1992, Archives of otolaryngology--head & neck surgery.

[38]  A. Beck,et al.  An inventory for measuring clinical anxiety: psychometric properties. , 1988, Journal of consulting and clinical psychology.

[39]  M. Gottlieb.  Continuous positive airway pressure. , 1981, Archives of surgery.

[40]  W. B. Webb,et al.  The first night effect: an EEG study of sleep. , 1966, Psychophysiology.